8-K current report · filed Nov 12, 2026

Aveanna Healthcare Holdings, Inc. (AVAH) 8-K Current Report: November 12, 2026

Item 2.02Item 7.01Item EX-99.1AVAH overview

Short answer

Aveanna Healthcare Holdings, Inc. (AVAH) filed an 8-K current report with the SEC on November 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Press release announces Aveanna’s financial results for the three and nine months ended October 3, 2026.

Aveanna Healthcare Holdings, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Press release announces Aveanna’s financial results for the three and nine months ended October 3, 2026
  • Investors should review Exhibit 99.1 for revenue, profitability, cash flow and guidance details

Item 7.01 · Regulation FD Disclosure

  • Item 7.01 incorporates Item 2.02 information, indicating earnings-related disclosure for Aveanna Healthcare
  • Investor-relevant details reside in Item 2.02 and its accompanying exhibit

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $695.5M, up 11.8%, with growth across PDS, HHH and MS segments
  • Net income $45.5M versus $14.1M, while diluted EPS increased to $0.20 from $0.06
  • Adjusted EBITDA $100.1M, up 25.0%, with margin expanding to 14.4% from 12.9%
  • Full-year guidance raised to revenue above $2.695B and Adjusted EBITDA above $374M
  • Liquidity included $197.8M cash and $68.7M securitization capacity against $1.521B total debt

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Aveanna Healthcare Holdings, Inc. 8-K filings

Get the next AVAH 8-K as it lands

Follow AVAH for push alerts, or ask the research agent what this filing means.